Securities Therapeutics Forum Daniel Vitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesNew yorkBeth israel medical centerAdams centerJosepha murrayJessica breuFriedrich hahnPaula schwartzJ thomas lamontEdna kaplanMartina wirthBeth israel deaconess medical centerInstitute for clinicalCeliac disease researchAdams center ancillary gymsDivision of gastroenterology